Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
Titel:
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
Auteur:
Taha, Zaid Arulanandam, Rozanne Maznyi, Glib Godbout, Elena Carter-Timofte, Madalina E. Kurmasheva, Naziia Reinert, Line S. Chen, Andrew Crupi, Mathieu J.F. Boulton, Stephen Laroche, Geneviève Phan, Alexandra Rezaei, Reza Alluqmani, Nouf Jirovec, Anna Acal, Alexandra Fekete, Emily E.F. Singaravelu, Ragunath Petryk, Julia Idorn, Manja Potts, Kyle G. Todesco, Hayley John, Cini Mahoney, Douglas J. Ilkow, Carolina S. Giguère, Patrick Alain, Tommy Côté, Marceline Paludan, Søren R. Olagnier, David Bell, John C. Azad, Taha Diallo, Jean-Simon